Pregabalin composition

Details for Australian Patent Application No. 2004308747 (hide)

Owner Pfizer Inc.

Inventors Schneider, Michael; Meyer-Wonnay, Hans Richard

Agent Allens Arthur Robinson

Pub. Number AU-A-2004308747

PCT Pub. Number WO2005/063229

Priority 03029117.3 18.12.03 EP

Filing date 6 December 2004

Wipo publication date 14 July 2005

International Classifications

A61K 31/197 (2006.01)

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/063229 Priority application(s): WO2005/063229

1 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004308749-CD40 antibody formulation and methods

2004308741-Multiparticulate formulations for oral delivery